The Board of Australian Pharmaceutical Industries Ltd. announced that Mark Smith has been appointed a Non-executive Director of the Company. Mr. Smith has also been nominated as Chair-elect following the decision of the current Chair Peter Robinson to retire at the Annual General Meeting to be held on 24 January 2018. Mr. Smith will become a member of the Audit and Risk Committee, replacing Mr. Gerard Masters in that role. Mr. Masters will continue to Chair the Remuneration Committee. Mr. Smith is currently a Non-executive Director of GUD Holdings Limited and was previously the Chair of Patties Foods Limited for three years and a Non-executive Director of Toll Holdings Limited for eight years.